These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1932024

  • 1. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM, Conrad HE, Pizzo SV.
    Biochemistry; 1991 Nov 12; 30(45):10999-1003. PubMed ID: 1932024
    [Abstract] [Full Text] [Related]

  • 2. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation.
    Edelberg JM, Pizzo SV.
    Biochemistry; 1990 Jun 26; 29(25):5906-11. PubMed ID: 2143417
    [Abstract] [Full Text] [Related]

  • 3. Modulation of tissue plasminogen activator-catalyzed plasminogen activation by synthetic peptides derived from the amino-terminal heparin binding domain of fibronectin.
    Stack MS, Pizzo SV.
    J Biol Chem; 1993 Sep 05; 268(25):18924-8. PubMed ID: 8360182
    [Abstract] [Full Text] [Related]

  • 4. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM, Reilly CF, Pizzo SV.
    J Biol Chem; 1991 Apr 25; 266(12):7488-93. PubMed ID: 1708387
    [Abstract] [Full Text] [Related]

  • 5. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
    Eastman D, Wurm FM, van Reis R, Higgins DL.
    Biochemistry; 1992 Jan 21; 31(2):419-22. PubMed ID: 1731899
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator.
    Andrade-Gordon P, Strickland S.
    J Biol Chem; 1989 Sep 15; 264(26):15177-81. PubMed ID: 2504719
    [Abstract] [Full Text] [Related]

  • 7. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS, Pizzo SV.
    Arch Biochem Biophys; 1994 Feb 15; 309(1):117-22. PubMed ID: 8117101
    [Abstract] [Full Text] [Related]

  • 8. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride.
    Young TN, Edelberg JM, Stack S, Pizzo SV.
    Arch Biochem Biophys; 1992 Aug 01; 296(2):530-8. PubMed ID: 1385938
    [Abstract] [Full Text] [Related]

  • 9. Regulation of plasminogen activation by components of the extracellular matrix.
    Stack S, Gonzalez-Gronow M, Pizzo SV.
    Biochemistry; 1990 May 22; 29(20):4966-70. PubMed ID: 2114170
    [Abstract] [Full Text] [Related]

  • 10. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.
    Liang JF, Li Y, Yang VC.
    Thromb Res; 2000 Mar 01; 97(5):349-58. PubMed ID: 10709911
    [Abstract] [Full Text] [Related]

  • 11. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
    Fischer BE, Will H.
    Biochim Biophys Acta; 1990 Oct 18; 1041(1):48-54. PubMed ID: 2145980
    [Abstract] [Full Text] [Related]

  • 12. Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.
    Gonzalez-Gronow M, Gomez CF, de Ridder GG, Ray R, Pizzo SV.
    J Biol Chem; 2014 Sep 05; 289(36):25166-76. PubMed ID: 25059665
    [Abstract] [Full Text] [Related]

  • 13. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 14. The effects of polysaccharides on plasminogen activation by single chain-and two chain-tissue plasminogen activator.
    Kawamura H, Watanabe I, Urano T, Takada Y, Takada A.
    Thromb Res; 1991 Jun 01; 62(5):481-90. PubMed ID: 1654600
    [Abstract] [Full Text] [Related]

  • 15. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E.
    Lab Invest; 1994 Dec 01; 71(6):828-37. PubMed ID: 7807964
    [Abstract] [Full Text] [Related]

  • 16. Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator.
    Urano T, Sator de Serrano V, Gaffney PJ, Castellino FJ.
    Biochemistry; 1988 Aug 23; 27(17):6522-8. PubMed ID: 3146348
    [Abstract] [Full Text] [Related]

  • 17. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
    Bell J, Duhon S, Doctor VM.
    Blood Coagul Fibrinolysis; 2003 Apr 23; 14(3):229-34. PubMed ID: 12695744
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.
    Lang D, Williams T, Phillips A, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 2004 Apr 23; 29(4):269-75. PubMed ID: 15726889
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S, McMillan E, Doctor V.
    Blood Coagul Fibrinolysis; 2010 Jul 23; 21(5):425-30. PubMed ID: 20445443
    [Abstract] [Full Text] [Related]

  • 20. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen.
    Schielen WJ, Adams HP, Voskuilen M, Tesser GI, Nieuwenhuizen W.
    Blood Coagul Fibrinolysis; 1991 Jun 23; 2(3):465-70. PubMed ID: 1932532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.